The compound, furthermore, inhibited growth and proliferation of human hepatocellular carcinoma cells by apoptosis induction (Yuan et al., 2004) and showed additive effects with taxol against Tau protein-related resistance in MCF-7 cells (Lin et al., 2017). This evidence concerns the gene MAPT and hepatocellular carcinoma.